Standout Papers

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alz... 2005 2026 2012 2019 1.2k
  1. Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease (2014)
    Rachelle S. Doody, Ronald G. Thomas et al. New England Journal of Medicine
  2. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease (2005)
    Gorazd B. Stokin, Concepción Lillo et al. Science
  3. A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease (2013)
    Rachelle S. Doody, Rema Raman et al. New England Journal of Medicine
  4. Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease (2010)
    Joseph F. Quinn, Rema Raman et al. JAMA
  5. The Preclinical Alzheimer Cognitive Composite (2014)
    Michael Donohue, Reisa A. Sperling et al. JAMA Neurology
  6. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia (2020)
    Suzanne Craft, Rema Raman et al. JAMA Neurology
  7. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals (2020)
    Reisa A. Sperling, Michael Donohue et al. JAMA Neurology
  8. Trial of Solanezumab in Preclinical Alzheimer’s Disease (2023)
    Reisa A. Sperling, Michael Donohue et al. New England Journal of Medicine
  9. The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease (2022)
    Michael S. Rafii, Reisa A. Sperling et al. Alzheimer s & Dementia

Immediate Impact

8 from Science/Nature 81 standout
Sub-graph 1 of 16

Citing Papers

Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease
2025 Standout
The epidemiology of Parkinson's disease
2024 Standout
2 intermediate papers

Works of Rema Raman being referenced

Early-stage Alzheimer disease: getting trial-ready
2022
Plasma Urate and Progression of Mild Cognitive Impairment
2008
and 2 more

Author Peers

Author Last Decade Papers Cites
Rema Raman 3161 4406 2146 2206 225 12.5k
Matti Viitanen 5538 4844 1545 2199 282 16.0k
Mary Sano 4813 3343 1346 1453 251 12.5k
Gunhild Waldemar 5026 2618 1498 2493 346 12.9k
Kathleen A. Welsh‐Bohmer 5726 4863 1048 1486 231 14.3k
Kamal Masaki 3875 5465 1524 2694 264 17.8k
Rhoda Au 6039 4579 2550 1813 297 17.7k
Raimo Sulkava 3932 3704 972 1465 222 12.5k
Krista L. Lanctôt 5388 3841 2076 1217 440 19.5k
Melville R. Klauber 2299 4144 3177 4970 152 20.8k
Keith Wesnes 3782 2607 1034 1980 315 16.3k

All Works

Loading papers...

Rankless by CCL
2026